CVS Health Change in Accounts Payable 2010-2025 | CVS

CVS Health annual/quarterly change in accounts payable history and growth rate from 2010 to 2025. Change in accounts payable can be defined as the increase or decrease in trade payables for the given period.
  • CVS Health change in accounts payable for the quarter ending March 31, 2025 was $2.619B, a 285.74% decline year-over-year.
  • CVS Health change in accounts payable for the twelve months ending March 31, 2025 was $8.314B, a 82.48% increase year-over-year.
  • CVS Health annual change in accounts payable for 2024 was $2.335B, a 35.46% decline from 2023.
  • CVS Health annual change in accounts payable for 2023 was $3.618B, a 15.07% decline from 2022.
  • CVS Health annual change in accounts payable for 2022 was $4.26B, a 47% increase from 2021.
CVS Health Annual Change in Accounts Payable
(Millions of US $)
2024 $2,335
2023 $3,618
2022 $4,260
2021 $2,898
2020 $2,769
2019 $3,550
2018 $2,329
2017 $1,710
2016 $2,189
2015 $2,834
2014 $1,742
2013 $1,024
2012 $1,147
2011 $1,128
2010 $-40
2009 $4
Sector Industry Market Cap Revenue
Medical Medical Services $85.338B $372.809B
CVS Health Corporation is a pharmacy innovation company. Its offerings include pharmacy benefit management services, mail order, retail and specialty pharmacy, disease management programs, and retail clinics. The Company serves employers, insurance companies, unions, government employee groups, managed care organizations and other sponsors of health benefit plans, and individuals under the CVS Caremark Pharmacy Services, Caremark, CVS Caremark, CarePlus CVS/pharmacy, RxAmerica, Accordant, SilverScript, and Novologix names. CVS Health Corporation, formerly known as CVS Caremark Corporation, is headquartered in Woonsocket, Rhode Island.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $143.613B 26.94
Elevance Health (ELV) United States $86.883B 11.21
Cencora (COR) United States $57.283B 19.93
DiDi Global (DIDIY) China $22.826B 24.25
Natera (NTRA) United States $22.577B 0.00
Labcorp Holdings (LH) United States $21.856B 17.73
BioMerieux (BMXMF) France $16.861B 0.00
EUROFINS SCIENT (ERFSF) Luxembourg $13.669B 0.00
Solventum (SOLV) United States $12.768B 13.52
ICON (ICLR) Ireland $11.763B 10.94
CochLear (CHEOY) Australia $11.550B 0.00
Revvity (RVTY) United States $11.024B 18.97
Doximity (DOCS) United States $10.503B 48.63
Viatris (VTRS) United States $10.469B 3.60
HealthEquity (HQY) United States $9.059B 39.68
Avantor (AVTR) United States $8.906B 12.94
Medpace Holdings (MEDP) United States $8.572B 22.77
Sonic Healthcare (SKHHY) Australia $8.393B 0.00
Charles River Laboratories (CRL) United States $7.340B 14.38
Amplifon S.p.A (AMFPF) Italy $5.378B 29.44
Bausch + Lomb (BLCO) Canada $4.361B 25.69
BrightSpring Health Services (BTSG) United States $3.724B 34.16
Sotera Health (SHC) United States $3.244B 18.43
Alignment Healthcare (ALHC) United States $2.956B 0.00
Surgery Partners (SGRY) United States $2.914B 37.90
Concentras Parent (CON) United States $2.749B 15.89
Organon (OGN) United States $2.610B 2.77
Ardent Health (ARDT) United States $1.881B 8.02
Premier (PINC) United States $1.858B 14.11
GeneDx Holdings (WGS) United States $1.842B 70.96
Progyny (PGNY) United States $1.803B 39.68
PACS (PACS) United States $1.573B 0.00
GoodRx Holdings (GDRX) United States $1.561B 31.21
Teladoc Health (TDOC) United States $1.203B 0.00
Pediatrix Medical (MD) United States $1.203B 9.15
Establishment Labs Holdings (ESTA) $1.083B 0.00
CareDx (CDNA) United States $1.035B 16.17
Ryman Healthcare (RYHTY) New Zealand $1.011B 0.00
Agilon Health (AGL) United States $0.890B 0.00
AMN Healthcare Services Inc (AMN) United States $0.826B 7.73
QDM (QDMI) Hong Kong, SAR China $0.763B 0.00
Nutex Health (NUTX) United States $0.679B 10.28
LifeMD (LFMD) United States $0.566B 0.00
Embecta (EMBC) United States $0.559B 3.76
Enhabit (EHAB) United States $0.495B 40.75
InnovAge Holding (INNV) United States $0.478B 0.00
Auna S.A (AUNA) Luxembourg $0.467B 10.52
SBC Medicals (SBC) United States $0.459B 0.00
Sonida Senior Living (SNDA) United States $0.453B 0.00
Omada Health (OMDA) $0.440B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.411B 0.00
Performant Healthcare (PHLT) United States $0.255B 0.00
Oncology Institute (TOI) United States $0.220B 0.00
Beauty Health (SKIN) United States $0.193B 0.00
KindlyMD (KDLY) United States $0.150B 0.00
DocGo (DCGO) United States $0.148B 24.17
Pheton Holdings (PTHL) China $0.114B 0.00
So-Young (SY) China $0.097B 0.00
KindlyMD (NAKA) United States $0.083B 0.00
OncoCyte (OCX) United States $0.076B 0.00
Sera Prognostics (SERA) United States $0.064B 0.00
Basel Medical Group (BMGL) Singapore $0.064B 0.00
NeueHealth (NEUE) United States $0.061B 0.00
Ascend Wellness Holdings (AAWH) United States $0.060B 0.00
IceCure Medical (ICCM) Israel $0.054B 0.00
Biodesix (BDSX) United States $0.042B 0.00
ModivCare (MODV) United States $0.042B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.028B 0.00
Intelligent Bio Solutions (INBS) United States $0.013B 0.00
SeaStar Medical Holding (ICU) United States $0.012B 0.00
Co-Diagnostics (CODX) United States $0.009B 0.00
XWELL (XWEL) United States $0.005B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
Aclarion (ACON) United States $0.004B 0.00
INVO Fertility (IVF) United States $0.003B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
NewGenIvf Group (NIVF) Thailand $0.001B 0.00
Cano Health (CANOQ) United States $0.000B 0.00